The platform offers modern AI and molecular modeling tools for early-stage drug development tasks.
Related Posts
Bank of England reviews AI rules for agentic AI in finance
- admin
- July 1, 2026
- 5 min read
- 0
The Bank of England is reviewing whether existing rules can cover the use of agentic AI in finance, including payments, trading, cybersecurity, and operations. Deputy Governor Sarah Breeden said existing regulatory frameworks were not designed for AI agents that can act without direct human instruction. Speaking at the European Central Bank Forum on central banking […]
Data Intelligence: Building Your Competitive Advantage in the Era of AI
- admin
- August 24, 2026
- 1 min read
- 0
To keep pace with modern business, data strategy is shifting toward more autonomous real-time systems that deliver intelligence at the moment decisions are made. Driven by agentic AI, modern data teams are moving beyond simply looking at what happened. Now they’re automating complex workflows that analyze what’s happening, anticipate what might happen next, and recommend […]
Aureka Releases OpenDDE, an Open-Source Drug Discovery Engine for AI-Driven Therapeutic Discovery
- admin
- July 8, 2026
- 5 min read
- 0
All-atom biomolecular foundation model uses co-folding as the entry point to a scalable drug discovery engine; the release marks a concrete step toward advancing open scientific AI for future biomedical research that benefit patients. LAGUNA HILLS, Calif. and SHANGHAI, July 7, 2026 — Aureka, an AI TechBio company building infrastructure for AI-driven biologics discovery, has […]
Avondale RSA shuts bar as rising costs end decades-old tradition
- admin
- July 3, 2026
- 1 min read
- 0
President Gaye Mantell says funds must support veterans, not prop up a bar.